About Dr. McCarty

Interventional Pain Management Physician & Anesthesiologist in Austin, Cedar Park and Marble Falls, TX

Board-certified anesthesiologist Matthew McCarty, MD, offers compassionate care to patients with chronic pain conditions at the Austin, Texas, office of Balcones Pain Consultants.

Dr. McCarty has a subspecialty certification in pain medicine. He understands that chronic pain robs people of their time and energy, affects their relationships, and ultimately leaves them with a sense of despair and isolation. He is committed to seeing his patients succeed in overcoming pain and restoring them to the life they love.

Dr. McCarty received his undergraduate degree from Baylor University in Waco, Texas, and his medical degree from the University of Oklahoma College of Medicine in Oklahoma City, Oklahoma. 

He completed his anesthesiology residency at the University of Texas Health Science Center in San Antonio, Texas, and successfully practiced in Tyler, Texas, for 14 years.

After deciding to pursue his growing interest in chronic pain medicine, Dr. McCarty completed a fellowship in interventional chronic pain management at the University of South Florida in Tampa, Florida. He and his family then moved to Austin.

Dr. McCarty aims to develop partnerships with his patients and return them to their community using a broad range of treatments. Patients’ rehabilitation programs might include physical therapy, medications, behavioral therapies, and advanced interventional procedures.

Dr. McCarty is also committed to medication monitoring and prescription fulfillment research and innovation. 

He is the founder and CEO of Austin-based Genotox Labs, primarily specializing in proprietary patented DNA urinary drug monitoring methods. Genotex also undertakes genetic testing of the different ways patients metabolize medication.

One of Dr. McCarty’s proudest achievements has been presenting the lab’s ToxProtect™ method. ToxProtect helps other labs improve their quality assurance procedures against  labeling errors and detect substitute synthetic or other human urine in sobriety and medication monitoring.